Neisseria gonorrhoeae in the province of Ontario. The increase, from 4% in 2002 to 28% in
2006, has been occurring in a time of rising rates of gonorrhea. The epidemiologic …

Objective: To study the serologic characters and antibiotic susceptibilities of quinolone-
resistant Neisseria gonorrhoeae in Hong Kong. Study Design: Sixty-nine strains of Neisseria …

Background: Quinolone-resistant Neisseria gonorrhoeae has swiftly emerged in Canada.
We sought to determine its prevalence in the province of Ontario and to investigate risk …

The percentage of quinolone-resistant Neisseria gonorrhoeae isolated in London increased
between 2000 and 2003, from 0.9% to 7.9% of total isolates. This increase was investigated …

The increasing prevalence of quinolone-resistant Neisseria gonorrhoeae (QRNG) in the
United States is a cause for concern. Detecting resistance is complicated by the widespread …

Background: Canada conducts surveillance of penicillin, tetracycline, erythromycin,
spectinomycin, ciprofloxacin, cefixime, and ceftriaxone susceptibilities in Neisseria …

Background Neisseria gonorrhoeae have acquired resistance to many antimicrobials,
including third generation cephalosporins and azithromycin, which are the current …

Background Ciprofloxacin (500 mg orally, single dose) is one of the recommended therapies
for gonorrhea in Canada. In Canada, the first ciprofloxacin-resistant (CipR) Neisseria …

Study Design: Quinolone minimal inhibatory concentrations, phenotype, and geographic
source of quinolone-resistant Neisseria gonorrhoeae isolated in Sydney from 1995 to 1997 …

Neisseria gonorrhoeae antimicrobial drug resistance has emerged worldwide; however, the
situation in sub-Saharan Africa is not well documented. We investigated the molecular …